NASDAQ:KYMR

Kymera Therapeutics Stock Forecast

etoro logo Buy KYMR
*Your capital is at risk
$90.43
+0.530 (+0.590%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of KYMR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add KYMR to Watchlist?
Some Reasons Why To Add KYMR:
  • +97.1% price growth over the last year
  • High gross margin of 100.0%
  • Low bankruptcy risk (Altman Z-Score: 32.14)
PDF

Kymera Therapeutics Inc. stock downgraded to Hold/Accumulate
(Updated on Jun 18, 2026)

Buy or Hold candidate since Jun 11, 2026 Gain 9.00%

The Kymera Therapeutics Inc. stock price gained 0.590% on the last trading day (Thursday, 18th Jun 2026), rising from $89.90 to $90.43. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.69% from a day low at $89.18 to a day high of $92.47. The price has risen in 7 of the last 10 days and is up by 21.2% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 112 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $106.03 million.

The stockhas broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $88.31, a level that may pose a second chance to hit a runner. According to fan-theory $105.74 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

KYMR Signals & Forecast

The Kymera Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $85.82 and $81.48. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 26.85%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Kymera Therapeutics Inc. stock

Kymera Therapeutics Inc. finds support from accumulated volume at $89.90 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.29 between high and low, or 3.69%. For the last week, the stock has had daily average volatility of 4.72%.

Our recommended stop-loss: $87.07 (-3.72%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (KYMR) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Kymera Therapeutics Inc. to open at $90.69, and during the day (based on 14 day Average True Range), to move between $88.55 and $92.31, which gives a possible trading interval of +/-$3.76 (+/-4.25%) up or down from last closing price. If Kymera Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 4.25% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $89.90, some $0.530 (0.59%) from the current price of $90.43, our system finds the risk reward attractive.

Is Kymera Therapeutics Inc. stock A Buy?

Kymera Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $90.69 ( 0.291%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

KYMR Performance

Trading levels for KYMR

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 93.98 3.93%
R2 92.73 2.54%
R1 91.95 1.68%
Price 90.43
S1 89.44 -1.10%
S2 88.66 -1.96%
S3 87.40 -3.35%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 90.43
S1 89.90 -0.586%
S2 85.59 -5.35%
S3 83.29 -7.90%

FAQ

What is the symbol for Kymera Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Kymera Therapeutics Inc. is KYMR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Kymera Therapeutics Inc. Stock?
Kymera Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

How to buy Kymera Therapeutics Inc. Stock?
Kymera Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Kymera Therapeutics Inc. Stock.

What's the current price of Kymera Therapeutics Inc. Stock?
As of the end of day on the Jun 18, 2026, the price of an Kymera Therapeutics Inc. (KYMR) share was $90.43.

What is the 52-week high and low for Kymera Therapeutics Inc. Stock?
The 52-week high for Kymera Therapeutics Inc. Stock is $103.00 and the 52-week low is $36.65.

What is the market capitalization of Kymera Therapeutics Inc. Stock?
As of the Jun 18, 2026, the market capitalization of Kymera Therapeutics Inc. is 7.439B.

When is the next earnings date for Kymera Therapeutics Inc.?
The upcoming earnings date for Kymera Therapeutics Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT KYMERA THERAPEUTICS INC.
Kymera Therapeutics
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation ...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE